If You Invested $5,000 in AbbVie IPO, This Is How Much Money You'd Have Now
AbbVie (NYSE: ABBV) was officially launched on Jan. 2, 2013 as a spinoff from Abbott Laboratories (NYSE: ABT). That was the first day the company traded on the New York Stock Exchange. The move was made so that Abbott could focus on its business of manufacturing medical devices and equipment, while AbbVie would prioritize pharmaceuticals.
Source Fool.com
